We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+9.09%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$5.62B
AUM Growth
+$874M
Cap. Flow
+$536M
Cap. Flow %
9.53%
Top 10 Hldgs %
66.07%
Holding
710
New
128
Increased
146
Reduced
103
Closed
149

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$779M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$358M
3
NEWR
New Relic, Inc.
NEWR
+$258M
4
DEN
Denbury Inc.
DEN
+$175M
5
VMW
VMware, Inc
VMW
+$165M

Top Sells

Rank Stock Value
1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$230M
2
PDCE
PDC Energy, Inc.
PDCE
+$221M
3
UNVR
Univar Solutions Inc.
UNVR
+$219M
4
FOCS
Focus Financial Partners Inc. Class A
FOCS
+$146M
5
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$141M

Sector Composition

Rank Sector Weight
1 Technology 34.82%
2 Healthcare 28.77%
3 Real Estate 5.15%
4 Financials 4.39%
5 Consumer Discretionary 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AURA icon
401
Aura Biosciences
AURA
$810M
$395K 0.01%
44,000
– –
AFMD
402
DELISTED
Affimed
AFMD
$392K 0.01%
82,000
+47,910
+141% +$264K
CTRE icon
403
CareTrust REIT
CTRE
$9.66B
$385K 0.01%
18,800
-6,470
-26% -$131K
ESS icon
404
Essex Property Trust
ESS
$18.4B
$382K 0.01%
1,800
-34,700
-95% -$8.14M
MRSN
405
DELISTED
Mersana Therapeutics
MRSN
$376K 0.01%
+11,857
New +$564K
LKFT
406
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.76B
$376K 0.01%
10,888
-46,000
-81% -$1.79M
EQIX icon
407
Equinix
EQIX
$104B
$363K 0.01%
+500
New +$387K
VIR icon
408
Vir Biotechnology
VIR
$1.51B
$356K 0.01%
+38,000
New +$542K
ROIC
409
DELISTED
Retail Opportunity Investments Corp.
ROIC
$342K 0.01%
27,600
-554,094
-95% -$7.64M
JETS icon
410
PUT
US Global Jets ETF
JETS
$797M
$340K 0.01%
250,000
+100,000
+67% +$1.97M
LYV icon
411
PUT
Live Nation Entertainment
LYV
$42.9B
$339K 0.01%
+37,500
New +$3.27M
CTMX icon
412
CytomX Therapeutics
CTMX
$745M
$335K 0.01%
259,965
– –
PEN icon
413
Penumbra
PEN
$12.8B
$331K 0.01%
1,369
– –
EXPE icon
414
Expedia Group
EXPE
$37.3B
$309K 0.01%
3,000
-117,500
-98% -$13M
AVTR icon
415
Avantor
AVTR
$9.1B
$305K 0.01%
14,470
-93,000
-87% -$1.98M
CYPH
416
Cypherpunk Technologies Inc
CYPH
$76.1M
$303K 0.01%
219,434
+80,000
+57% +$186K
ABOS icon
417
Acumen Pharmaceuticals
ABOS
$167M
$289K 0.01%
69,538
-10,000
-13% -$61.8K
SMH icon
418
PUT
VanEck Semiconductor ETF
SMH
$72.4B
$287K 0.01%
+105,000
New +$15.9M
ORIC icon
419
PUT
Oric Pharmaceuticals
ORIC
$1.35B
$285K 0.01%
+100,000
New +$819K
RNG icon
420
RingCentral
RNG
$5.37B
$271K ﹤0.01%
9,155
-1,000
-10% -$33.2K
VZIO
421
DELISTED
VIZIO Holding Corp.
VZIO
$271K ﹤0.01%
50,000
-150,000
-75% -$963K
INTC icon
422
Intel
INTC
$501B
$267K ﹤0.01%
+7,500
New +$261K
H icon
423
PUT
Hyatt Hotels
H
$16.8B
$260K ﹤0.01%
102,000
-135,000
-57% -$15.4M
APLS
424
CALL
DELISTED
Apellis Pharmaceuticals
APLS
$248K ﹤0.01%
50,000
+25,000
+100% +$1.1M
PRQR icon
425
ProQR Therapeutics
PRQR
$272M
$246K ﹤0.01%
189,328
– –
15 16
17
18 19

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q3 2023 Portfolio in Review

As of Q3 2023, UBS O'Connor held 710 positions worth $5.62B, up 18% from $4.75B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

UBS O'Connor deployed $536M of net new capital in Q3 2023, opening 128 new positions and adding to 146 existing holdings. Its largest new stake was Denbury Inc.: 1,931,731 shares worth $189M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 16% a quarter earlier, followed by Healthcare and Real Estate.

On the sell side, the largest reduction was Seagen Inc. Common Stock, an estimated $19.7M trimmed.

  • UBS O'Connor's largest Q3 2023 buy was Denbury Inc.: 1,931,731 shares worth $189M.
  • UBS O'Connor added most to Activision Blizzard in Q3 2023, an estimated $779M increase.
  • UBS O'Connor's biggest Q3 2023 reduction was Seagen Inc. Common Stock, cutting an estimated $19.7M.
  • UBS O'Connor fully exited IVERIC bio, Inc. Common Stock in Q3 2023, selling an estimated $230M.
  • UBS O'Connor's ten largest holdings make up 66% of its $5.62B portfolio in Q3 2023.
  • UBS O'Connor opened 128 new positions and closed 149 in Q3 2023.
  • UBS O'Connor's portfolio value rose 18% quarter-over-quarter to $5.62B.

Based on UBS O'Connor's 13F filing for Q3 2023, filed 14 Nov 2023.